Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
A Comparison of Standard Dose of Ibuprofen Alone, Alternating, or Combined With Acetaminophen for the Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
1 other identifier
interventional
75
1 country
1
Brief Summary
The purpose of this study is to investigate the effectiveness of various oral analgesic regimens in minimizing post-operative pain and discomfort in young children following dental rehabilitation under general anesthesia (DRGA). In this randomized controlled trial, three analgesic regimens following DRGA in Franciscan Children's Hospital will be compared using both self-report and behavioral measures. The analgesic therapies to be investigated are ibuprofen monotherapy, alternating ibuprofen and acetaminophen dual-therapy, and combined ibuprofen and acetaminophen dual-therapy. For the purposes of this study, combined therapy is defined as the simultaneous administration of acetaminophen and ibuprofen at regular intervals, whereas alternating therapy is defined as one analgesic (acetaminophen or ibuprofen) administered within a 3 hour interval of the other.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 24, 2024
CompletedFirst Posted
Study publicly available on registry
January 3, 2025
CompletedStudy Start
First participant enrolled
April 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
April 2, 2026
March 1, 2026
1.9 years
December 24, 2024
March 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Dental discomfort assessed by the abbreviated DDQ-8
The Dental Discomfort Questionnaire (DDQ-8)-Abbreviated is an 8 item questionnaire completed by the caregiver. Responses to each question are Yes=2 and No=0 creating a possible range of total scores of 0-16 with higher scores correlated with more dental discomfort.
day of surgery, one pay post surgery, 2 days post surgery, 15 days post surgery
Pain assessment based on the FLACC
The Face, Legs, Activity, Cry, and Consolability (FLACC) scale assesses pain by the caregiver on 5 aspects of behavior: (F) facial expression; (L) leg movement; (A) activity; (C) cry; (C) consolability. Each behavior is rated 0 to 2 resulting in a range of scores from 0 to 10 with higher scores correlated with more pain.
day of surgery, one pay post surgery, 2 days post surgery, 15 days post surgery
Study Arms (3)
Alternating analgesics
EXPERIMENTALParticipants randomized into this arm will be given alternating Ibuprofen and Acetaminophen every 6 hours, alternating the two medications every 3 hours: first dose ibuprofen, three hours later acetaminophen for 24 hours.
Simultaneous post-operative analgesics
EXPERIMENTALParticipants randomized into this arm will be given simultaneous Ibuprofen and Acetaminophen every 6 hours for 24 hours.
Control Standard of Care
ACTIVE COMPARATORParticipants randomized into this arm will be given Ibuprofen every 6 hours for 24 hours.
Interventions
10 mg/kg/dose of ibuprofen will be given every 6 hours for 24 hours post surgery
15 mg/kg/dose of acetominophen will be given every 6 hours for 24 hours post surgery
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) I-II
- Requiring Oral Rehabilitation under General Anesthesia
- Possess legal guardians proficient in English
- Not have a history of any adverse/allergic reaction to nonsteroidal anti-inflammatory drugs (NSAIDs) or Acetaminophen
You may not qualify if:
- ASA III or IV
- Asthma diagnosis
- Contraindication to acetaminophen or ibuprofen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Universitylead
- Franciscan Hospital For Children, INC.collaborator
Study Sites (1)
Franciscan Children's Hospital
Brighton, Massachusetts, 02135, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Keri Discepolo, DDS MPH
BU Goldman School of Dental Medicine, Pediatrics
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 24, 2024
First Posted
January 3, 2025
Study Start
April 16, 2025
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
April 2, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share